DEVELOPMENT AND APPLICATION OF ZINC NANOPARTICLES IN THE MEDICAL FIELD
DOI:
https://doi.org/10.55251/jmbfs.11061Keywords:
Zinc oxide, nanoparticles, cancer cells, research, medicineAbstract
Over the course of the last 10 years, there has been a significant amount of advancement in the subject of nanotechnology, which has demonstrated a great deal of potential not only in the realm of technological fields but also in the realm of medical research. It is possible to see a broad variety of uses for zinc oxide nanoparticles (ZnO-NPs) in the field of cancer research, which is being conducted using nanotechnology. Despite the fact that scientific knowledge is continually expanding in terms of its comprehension of the molecular foundation of cancer cells, the number of people who are diagnosed with cancer continues to rise. The World Health Organisation (WHO) forecasted that the number of cancer cases will rapidly rise over the following ten years.
ZnO-NPs have established themselves as a viable option for the treatment of cancer as a result of their capacity to trigger apoptosis in cancer cells. Due to the fact that ZnO nanoparticles have been shown to have anticancer, antibacterial, anti-diabetic, and anti-inflammatory activities, they have garnered a lot of interest in the field of biomedicine. The purpose of this study is to provide a summary of the recent research that have been conducted on the application of ZnO-NPS in the medical field.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Iveta Urban, Nikola Štefunková, Klaudia Jaszcza, Peter Massanyi
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers published in the Journal of Microbiology, Biotechnology and Food Sciences are published under a CC-BY licence (CC-BY 4.0). Published materials can be shared (copy and redistribute the material in any medium or format) and adapted (remix, transform, and build upon the material for any purpose, even commercially) with specifying the author(s).